Bioequivalence and Bioavailability Forum

Main page Policy Latest Posts Abbreviations

Clinical end point acceptance limit [Study Assessment]

posted by PKS – India, 2019-04-05 10:45 (2227 d 09:50 ago) – Posting: # 20125
Views: 5,163

Should I conclude bio-equivalence with the values of [-0.2025, 0.076] in clinical end point study. Can I assume it as within the interval of (-0.20, 0.20)

Edit: Category changed; see also this post #1. Please follow the Forum’s Policy. [Helmut]

Complete thread:

Clinical end point acceptance limitPKS 2019-04-05 08:45
- Clinical end point acceptance limit ElMaestro 2019-04-05 08:51
  - Clinical end point acceptance limit nobody 2019-04-05 09:04
  - Clinical end point acceptance limit PKS 2019-04-05 09:17
    - –0.2025 < –0.2, right? Helmut 2019-04-05 10:53

Admin contact
23,424 posts in 4,927 threads, 1,669 registered users;
146 visitors (0 registered, 146 guests [including 5 identified bots]).
Forum time: 20:35 CEST (Europe/Vienna)

We should not speak so that it is possible
for the audience to understand us,
but so that it is impossible
for them to misunderstand us. Quintilian

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC

Ing. Helmut Schütz

Bioequivalence and Bioavailability Forum

Clinical end point acceptance limit [Study As­sess­ment]

Complete thread:

Clinical end point acceptance limit [Study Assessment]